跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
hBD-2
首页
药物
hBD-2
hBD-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency
US 7833554 B2
申请人: EXPANSCIENCE LAB
优先权: 2004
CN
US
5 件公开
EXTERNAL SKIN BARRIER FUNCTION REPAIRING AGENT
EP 4659732 A1
申请人: SHISEIDO CO LTD
优先权: 2023
CN
EP
WO
4 件公开
Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases
US 7897579 B2
申请人: EXPANSCIENCE LAB
优先权: 2004
US
4 件公开
Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders
US 11192932 B2
申请人: AMOLYT PHARMA
优先权: 2018
CN
US
2 件公开
Use of lipopolysaccharides to manage corneal infections and wounds
US 6984622 B2
申请人: UNIV CALIFORNIA
优先权: 2002
US
2 件公开
Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
US 9089576 B2
申请人: PICCIRILLI ANTOINE
优先权: 2009
US
2 件公开
Prophylactic and therapeutic immunotherapy of propionibacterium acnes
CN 118561970 A
申请人: SANOFI PASTEUR LTD
优先权: 2020
CN
2 件公开
Methods and Agents for Modulating Cellular Activity
US 2008286287 A1
申请人: MURDOCH CHILDRENS RES INST
优先权: 2006
US
Use of sphingosylphosphorylcholine antagonist for restoring the expression of antimicrobial peptides
CN 101443347 A
申请人: AMOREPACIFIC CORP
优先权: 2006
CN
Novel cell-penetrating peptide
CN 103897032 A
申请人: ZHEJIANG REACHALL PHARMACEUTICAL CO LTD
优先权: 2012
CN
第 1 / 3 页
上一页
下一页
药物
反馈